Literature DB >> 17403783

HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.

Toru Sasaki1, Eugene C Gan, Andrew Wakeham, Sally Kornbluth, Tak W Mak, Hitoshi Okada.   

Abstract

In response to DNA damage, p53 undergoes post-translational modifications (including acetylation) that are critical for its transcriptional activity. However, the mechanism by which p53 acetylation is regulated is still unclear. Here, we describe an essential role for HLA-B-associated transcript 3 (Bat3)/Scythe in controlling the acetylation of p53 required for DNA damage responses. Depletion of Bat3 from human and mouse cells markedly impairs p53-mediated transactivation of its target genes Puma and p21. Although DNA damage-induced phosphorylation, stabilization, and nuclear accumulation of p53 are not significantly affected by Bat3 depletion, p53 acetylation is almost completely abolished. Bat3 forms a complex with p300, and an increased amount of Bat3 enhances the recruitment of p53 to p300 and facilitates subsequent p53 acetylation. In contrast, Bat3-depleted cells show reduced p53-p300 complex formation and decreased p53 acetylation. Furthermore, consistent with our in vitro findings, thymocytes from Bat3-deficient mice exhibit reduced induction of puma and p21, and are resistant to DNA damage-induced apoptosis in vivo. Our data indicate that Bat3 is a novel and essential regulator of p53-mediated responses to genotoxic stress, and that Bat3 controls DNA damage-induced acetylation of p53.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403783      PMCID: PMC1838535          DOI: 10.1101/gad.1534107

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  67 in total

1.  Acetylation of p53 inhibits its ubiquitination by Mdm2.

Authors:  Muyang Li; Jianyuan Luo; Christopher L Brooks; Wei Gu
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

2.  Inhibition of translation and induction of apoptosis by Bunyaviral nonstructural proteins bearing sequence similarity to reaper.

Authors:  Daniel A Colón-Ramos; Pablo M Irusta; Eugene C Gan; Michael R Olson; Jaewhan Song; Richard I Morimoto; Richard M Elliott; Mark Lombard; Robert Hollingsworth; J Marie Hardwick; Gary K Smith; Sally Kornbluth
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

3.  Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Authors:  Roger P Leng; Yunping Lin; Weili Ma; Hong Wu; Benedicte Lemmers; Stephen Chung; John M Parant; Guillermina Lozano; Razqallah Hakem; Samuel Benchimol
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

4.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 5.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 6.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

7.  Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.

Authors:  S Kaku; Y Iwahashi; A Kuraishi; A Albor; T Yamagishi; S Nakaike; M Kulesz-Martin
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

8.  The reaper-binding protein scythe modulates apoptosis and proliferation during mammalian development.

Authors:  Fabienne Desmots; Helen R Russell; Youngsoo Lee; Kelli Boyd; Peter J McKinnon
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

9.  Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells.

Authors:  I Ivanov; K C Lo; L Hawthorn; J K Cowell; Y Ionov
Journal:  Oncogene       Date:  2006-11-06       Impact factor: 9.867

10.  Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling.

Authors:  Thomas Kislinger; Brian Cox; Anitha Kannan; Clement Chung; Pingzhao Hu; Alexandr Ignatchenko; Michelle S Scott; Anthony O Gramolini; Quaid Morris; Michael T Hallett; Janet Rossant; Timothy R Hughes; Brendan Frey; Andrew Emili
Journal:  Cell       Date:  2006-04-07       Impact factor: 41.582

View more
  75 in total

1.  Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Therese Truong; Rayjean J Hung; Christopher I Amos; Xifeng Wu; Heike Bickeböller; Albert Rosenberger; Wiebke Sauter; Thomas Illig; H-Erich Wichmann; Angela Risch; Hendrik Dienemann; Rudolph Kaaks; Ping Yang; Ruoxiang Jiang; John K Wiencke; Margaret Wrensch; Helen Hansen; Karl T Kelsey; Keitaro Matsuo; Kazuo Tajima; Ann G Schwartz; Angie Wenzlaff; Adeline Seow; Chen Ying; Andrea Staratschek-Jox; Peter Nürnberg; Erich Stoelben; Jürgen Wolf; Philip Lazarus; Joshua E Muscat; Carla J Gallagher; Shanbeh Zienolddiny; Aage Haugen; Henricus F M van der Heijden; Lambertus A Kiemeney; Dolores Isla; Jose Ignacio Mayordomo; Thorunn Rafnar; Kari Stefansson; Zuo-Feng Zhang; Shen-Chih Chang; Jin Hee Kim; Yun-Chul Hong; Eric J Duell; Angeline S Andrew; Flavio Lejbkowicz; Gad Rennert; Heiko Müller; Hermann Brenner; Loïc Le Marchand; Simone Benhamou; Christine Bouchardy; M Dawn Teare; Xiaoyan Xue; John McLaughlin; Geoffrey Liu; James D McKay; Paul Brennan; Margaret R Spitz
Journal:  J Natl Cancer Inst       Date:  2010-06-14       Impact factor: 13.506

2.  E3 ubiquitin ligase activity and targeting of BAT3 by multiple Legionella pneumophila translocated substrates.

Authors:  Alexander W Ensminger; Ralph R Isberg
Journal:  Infect Immun       Date:  2010-06-14       Impact factor: 3.441

3.  Germline Genetic Variants and Lung Cancer Survival in African Americans.

Authors:  Carissa C Jones; William S Bush; Dana C Crawford; Angela S Wenzlaff; Ann G Schwartz; John K Wiencke; Margaret R Wrensch; William J Blot; Stephen J Chanock; Eric L Grogan; Melinda C Aldrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-15       Impact factor: 4.254

4.  A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer.

Authors:  Lele Liu; Xingguo Song; Xinyi Li; Linlin Xue; Shanshan Ding; Limin Niu; Li Xie; Xianrang Song
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-24       Impact factor: 4.553

5.  BAT3 interacts with transforming growth factor-beta (TGF-beta) receptors and enhances TGF-beta1-induced type I collagen expression in mesangial cells.

Authors:  Joon Hyeok Kwak; Sung Il Kim; Jin Kuk Kim; Mary E Choi
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

6.  BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis.

Authors:  Jiquan Chen; Yuan-Sheng Zang; Qingyu Xiu
Journal:  Tumour Biol       Date:  2014-07-04

7.  Human lymphocyte antigen B-associated transcript 2, 3, and 5 polymorphisms and haplotypes are associated with susceptibility of Kawasaki disease and coronary artery aneurysm.

Authors:  Yao-Yuan Hsieh; Ying-Ju Lin; Chi-Chen Chang; Da-Yuan Chen; Chin-Mu Hsu; Yu-Kuo Wang; Kung-Hao Hsu; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

8.  Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.

Authors:  Nathan C Horton; Stephen O Mathew; Porunelloor A Mathew
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  The promoter for intestinal cell kinase is head-to-head with F-Box 9 and contains functional sites for TCF7L2 and FOXA factors.

Authors:  Thomas W Sturgill; Paul B Stoddard; Steven M Cohn; Marty W Mayo
Journal:  Mol Cancer       Date:  2010-05-11       Impact factor: 27.401

10.  BAG-6 is essential for selective elimination of defective proteasomal substrates.

Authors:  Ryosuke Minami; Atsuko Hayakawa; Hiroki Kagawa; Yuko Yanagi; Hideyoshi Yokosawa; Hiroyuki Kawahara
Journal:  J Cell Biol       Date:  2010-08-16       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.